Mettler-Toledo International Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Mettler-Toledo International wird ein jährliches Gewinn- und Umsatzwachstum von 8.4% bzw. 4.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 11.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6119.2% betragen.
Wichtige Informationen
8.4%
Wachstumsrate der Gewinne
11.1%
EPS-Wachstumsrate
| Life Sciences Gewinnwachstum | 17.9% |
| Wachstumsrate der Einnahmen | 4.5% |
| Zukünftige Eigenkapitalrendite | 6,119.2% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 05 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Mettler-Toledo: Continued Excellence In Business Economics And Investment Debate
Aug 06Are Mettler-Toledo International Inc. (NYSE:MTD) Investors Paying Above The Intrinsic Value?
Jul 31
Is It Time To Consider Buying Mettler-Toledo International Inc. (NYSE:MTD)?
Jul 04Mettler-Toledo: Putting On A Lot Of Weight
May 22Mettler-Toledo International Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 12Risks To Shareholder Returns Are Elevated At These Prices For Mettler-Toledo International Inc. (NYSE:MTD)
Apr 30Are Mettler-Toledo International Inc. (NYSE:MTD) Investors Paying Above The Intrinsic Value?
Apr 03At US$1,350, Is It Time To Put Mettler-Toledo International Inc. (NYSE:MTD) On Your Watch List?
Mar 08Mettler-Toledo: Strong Cost Control And Pricing Growth Amid Weak Topline Growth
Feb 15What Mettler-Toledo International Inc.'s (NYSE:MTD) P/E Is Not Telling You
Jan 19Mettler-Toledo's 2023 Dip Exposes An Opportunity To Acquire This Compounder At A Discount
Jan 12Are Mettler-Toledo International Inc. (NYSE:MTD) Investors Paying Above The Intrinsic Value?
Dec 29Why Mettler-Toledo International Inc. (NYSE:MTD) Could Be Worth Watching
Dec 08Mettler-Toledo: Weak Chinese Pharma And Biopharma Continues To FY24
Nov 11Mettler-Toledo International (NYSE:MTD) Ticks All The Boxes When It Comes To Earnings Growth
Oct 06Mettler-Toledo: Precision Maker Is Off The Marks
Oct 01Mettler-Toledo International: China Deterioration Is Imminent
Sep 11Calculating The Intrinsic Value Of Mettler-Toledo International Inc. (NYSE:MTD)
Aug 25What Does Mettler-Toledo International Inc.'s (NYSE:MTD) Share Price Indicate?
Aug 07Mettler-Toledo Stock: Weighing The Potential Here
Jul 10Should You Be Adding Mettler-Toledo International (NYSE:MTD) To Your Watchlist Today?
Jun 26Why Mettler-Toledo International Inc. (NYSE:MTD) Could Be Worth Watching
May 04Here's Why We Think Mettler-Toledo International (NYSE:MTD) Is Well Worth Watching
Mar 25Mettler-Toledo International (NYSE:MTD) Has A Pretty Healthy Balance Sheet
Feb 17Mettler Toledo Q4 2022 Earnings Preview
Feb 08When Should You Buy Mettler-Toledo International Inc. (NYSE:MTD)?
Jan 30Mettler-Toledo: Overvalued Business With Balance Sheet Concerns
Jan 28Should You Be Adding Mettler-Toledo International (NYSE:MTD) To Your Watchlist Today?
Dec 18Mettler-Toledo: Long-Term Value Remains, Retain Buy Rating
Nov 15Calculating The Fair Value Of Mettler-Toledo International Inc. (NYSE:MTD)
Oct 31Is Mettler-Toledo International (NYSE:MTD) Using Too Much Debt?
Oct 13Is There Now An Opportunity In Mettler-Toledo International Inc. (NYSE:MTD)?
Sep 27We Ran A Stock Scan For Earnings Growth And Mettler-Toledo International (NYSE:MTD) Passed With Ease
Sep 12Mettler-Toledo upgraded at Stifel citing opportunity despite macro headwinds
Sep 06Mettler-Toledo International: A Great Science-Oriented Business
Aug 28A Look At The Intrinsic Value Of Mettler-Toledo International Inc. (NYSE:MTD)
Aug 01Mettler Toledo Non-GAAP EPS of $9.39 beats by $0.62, revenue of $978.39M beats by $26.58M
Jul 28Mettler-Toledo International (NYSE:MTD) Has A Rock Solid Balance Sheet
Jul 14Mettler-Toledo: Potential 7% Buyback Yield, Plenty Of Legs To Run
Jun 17If You Like EPS Growth Then Check Out Mettler-Toledo International (NYSE:MTD) Before It's Too Late
Jun 14Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 4,200 | 991 | 1,028 | 1,145 | 8 |
| 12/31/2025 | 3,995 | 916 | 945 | 1,018 | 11 |
| 12/31/2024 | 3,831 | 836 | 854 | 1,134 | 11 |
| 6/30/2024 | 3,750 | 786 | 899 | 993 | N/A |
| 3/31/2024 | 3,786 | 778 | 903 | 1,003 | N/A |
| 12/31/2023 | 3,788 | 789 | 861 | 966 | N/A |
| 9/30/2023 | 3,911 | 870 | 883 | 988 | N/A |
| 6/30/2023 | 3,954 | 889 | 858 | 969 | N/A |
| 3/31/2023 | 3,951 | 887 | 796 | 921 | N/A |
| 12/31/2022 | 3,920 | 873 | 738 | 859 | N/A |
| 9/30/2022 | 3,899 | 838 | 670 | 797 | N/A |
| 6/30/2022 | 3,865 | 821 | 692 | 814 | N/A |
| 3/31/2022 | 3,811 | 793 | 739 | 841 | N/A |
| 12/31/2021 | 3,718 | 769 | 801 | 909 | N/A |
| 9/30/2021 | 3,619 | 754 | 814 | 919 | N/A |
| 6/30/2021 | 3,474 | 712 | 778 | 880 | N/A |
| 3/31/2021 | 3,240 | 654 | 720 | 818 | N/A |
| 12/31/2020 | 3,085 | 603 | 632 | 725 | N/A |
| 9/30/2020 | 2,991 | 579 | 592 | 676 | N/A |
| 6/30/2020 | 2,938 | 547 | 537 | 626 | N/A |
| 3/31/2020 | 2,978 | 547 | 476 | 570 | N/A |
| 12/31/2019 | 3,009 | 561 | 506 | 603 | N/A |
| 9/30/2019 | 2,983 | 550 | 483 | 600 | N/A |
| 6/30/2019 | 2,964 | 547 | 448 | 574 | N/A |
| 3/31/2019 | 2,954 | 531 | 452 | 587 | N/A |
| 12/31/2018 | 2,936 | 513 | 422 | 565 | N/A |
| 9/30/2018 | 2,896 | 408 | 393 | 532 | N/A |
| 6/30/2018 | 2,860 | 387 | 387 | 528 | N/A |
| 3/31/2018 | 2,791 | 377 | N/A | 525 | N/A |
| 12/31/2017 | 2,725 | 376 | N/A | 516 | N/A |
| 9/30/2017 | 2,657 | 437 | N/A | 505 | N/A |
| 6/30/2017 | 2,609 | 433 | N/A | 504 | N/A |
| 3/31/2017 | 2,563 | 411 | N/A | 487 | N/A |
| 12/31/2016 | 2,508 | 384 | N/A | 461 | N/A |
| 9/30/2016 | 2,472 | 370 | N/A | 444 | N/A |
| 6/30/2016 | 2,426 | 357 | N/A | 425 | N/A |
| 3/31/2016 | 2,399 | 355 | N/A | 410 | N/A |
| 12/31/2015 | 2,395 | 353 | N/A | 440 | N/A |
| 9/30/2015 | 2,419 | 351 | N/A | 431 | N/A |
| 6/30/2015 | 2,444 | 347 | N/A | 432 | N/A |
| 3/31/2015 | 2,471 | 343 | N/A | 435 | N/A |
| 12/31/2014 | 2,486 | 338 | N/A | 419 | N/A |
| 9/30/2014 | 2,473 | 327 | N/A | 387 | N/A |
| 6/30/2014 | 2,435 | 317 | N/A | 382 | N/A |
| 3/31/2014 | 2,405 | 312 | N/A | 365 | N/A |
| 12/31/2013 | 2,379 | 306 | N/A | 346 | N/A |
| 9/30/2013 | 2,352 | 301 | N/A | 349 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: MTDDas prognostizierte Gewinnwachstum (8.4% pro Jahr) liegt über der Sparquote (2.5%).
Ertrag vs. Markt: MTDDie Erträge des Unternehmens (8.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.1% pro Jahr).
Hohe Wachstumserträge: MTDDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: MTDDie Einnahmen des Unternehmens (4.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).
Hohe Wachstumseinnahmen: MTDDie Einnahmen des Unternehmens (4.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: MTDDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (6119.2%).